glp 1 journal Issue 42: GLP-1 RA Drug Development GLP-1 Journal: Private GLP-1 Tracker

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, today announced that they have entered into an exclusive global license agreement for HS-10535, an investigational preclinical oral small molecule GLP-1 receptor agonist

From skin and hair concerns to shifts in spend and routines, this is a structural change, not a passing trend!!

This Best Practice Guide has been created by an independent Multi-Disciplinary Team

Meanwhile, Eli Lilly is advancing orforglipron, the first small-molecule GLP-1 receptor agonist for obesity

My clothes fit again, no more muffin top

Major kudos to Chad Janis and the entire Grns team